TELES Informationstechnologien AG (TLIK) Fair Value & Analysis
Healthcare · DE · Market cap €3.8M · ISIN DE000A289B07
What is TELES Informationstechnologien AG really worth?
Below-average quality, currently priced close to our fair value of €0.2256.
Risks
Fair value as of: Jul 17, 2026
From 2 valuation models · updated 45 days ago
Fair value updated Jul 17, 2026, revised from €59.99 to €0.2256 (−99.6%) since Jun 24, 2026. Share price −16.9% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The model range is unusually wide (€0.1126 to €0.3435). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range €0.0005 – €8.95 · fair‑value band €0.1126 – €0.3435 · the €0.2060 price screens below the €0.2256 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.
Analysis
TELES Informationstechnologien AG (TLIK) currently trades at €0.2060, while our model-based Fair Value estimate is €0.2256, implying the stock looks roughly 8.7% fairly valued today. The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector. How firm this estimate is: it rests on 2 models at a data quality of 91/100, which puts the evidence level at low.
Trailing-twelve-month revenue stands at €239K. It earns a return on equity of −96.8%. Fundamentals as of Jul 17, 2026
Our scenario range runs from €0.1126 (bear case) to €0.3435 (bull case); at €0.2060, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 72% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at 10%, TLIK screens cheaper than that median.
Notify me when TLIK reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 31 · Market factors (momentum, volatility) 23
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
TELES Informationstechnologien AG reported revenue of €658K in FY2024 versus €2.8M in FY2020, a compound −30.5%/yr. Reported net income was −€835K in FY2024.
Watch TLIK: get an alert when its fair value changes →
Peer Group
Medical Distribution · 82 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Distribution median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation MCK | $896.65 | $819.31 | −9% |
| Cencora, Inc COR | $327.79 | $211.07 | −36% |
| Cardinal Health, Inc CAH | $234.55 | $141.77 | −40% |
| Henry Schein, Inc HSIC | $88.46 | $71.70 | −19% |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.37 | ¥33.96 | +107% |
| Sinopharm Group 1099 | HK$16.75 | HK$58.67 | +250% |
| Galenica AG GALE | CHF 80.85 | CHF 61.79 | −24% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥21.03 | ¥28.65 | +36% |
| Jointown Pharmaceutical Group 600998 | ¥5.04 | ¥9.84 | +95% |
| Asker Healthcare Group ASKER | kr 74.40 | kr 28.26 | −62% |
Compare TELES Informationstechnologien AG with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is TELES Informationstechnologien AG (TLIK) overvalued or undervalued?
What is the fair value of TLIK?
What is the quality score of TLIK?
What is the revenue of TELES Informationstechnologien AG (TLIK)?
What is the net profit margin of TLIK?
Watch TELES Informationstechnologien AG in the live analysis
One click puts TELES Informationstechnologien AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.